creatinine measurement Market

The creatinine measurement market was valued at US$ 384.69 million in 2019 and is expected to grow at a CAGR of 8.0% from 2020 to 2027 to reach US$ 705.96 million by 2027.

Driving factors of the creatinine measurement market are increasing prevalence of chronic kidney disorders and growing prevalence of CKD among the geriatric population. However, factor like gradual shift toward novel biomarkers is likely to have negative impact on the growth of the market in the coming years. 

There is the growing prevalence of chronic kidney diseases. According to the American Society of Nephrology (ASN), there are ongoing recent advances in molecular diagnostics that are making ways to manage patients who are suffering from kidney-related disorders. Developments such as nucleic acid amplification and detection, proteomics, genomic analysis, and metabolomics have enabled several molecular diagnostic assays. Furthermore, the measurement of creatinine concentration in serum or plasma has been widely used in clinical chemistry to assess the functioning of kidneys. Based on CKD stages, the creatinine levels can provide a comprehensive analysis of kidneys. Glomerular filtration rate, an essential basis for the identification of chronic kidney disease, is determined by creatinine marker. Due to its efficiency for the analysis of kidney function, Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommended the use of creatinine measurement for kidney screening in 2012. Therefore, increasing chronic kidney disorders coupled with benefits of creatinine measurement to understand the condition of kidneys is likely to boost the demand for creatinine measurement devices during the forecast period.

The global creatinine measurement is segmented by product, type, sample type, and end user. The creatinine measurement market, by product, is segmented into kits and reagents. The reagent segment held the largest share of the market in 2019. The segment is also anticipated to register the highest CAGR in the market during the forecast period. Based on sample type, the market is segmented into blood and urine. The blood s segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period. Based on end user, the creatinine measurement market is segmented into hospital, diagnostic laboratories, and others. The diagnostic laboratories held the largest share of the market in 2019 and is expected to register fastest growth.

Some of the essential primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Organisation for Economic Co-operation and Development, National Kidney Foundation, Saudi Society of Nephrology and Transplantation, and among others.